Warning letter
Heartsine Technologies, LTD: warning letter of Apr 23, 2008
FDA warning letter UCM1048326 · Center for Devices and Radiological Health
Key facts
| Reference number | UCM1048326 |
|---|---|
| Company | Heartsine Technologies, LTD |
| Subject | CGMP/QSR/Medical Devices/Adulterated/Misbranded |
| Issue date | Apr 23, 2008 |
| Posted date | Apr 23, 2008 |
| Issuing office | Center for Devices and Radiological Health |
| Product type | Devices |
| CFR sections cited | 801.109, 820 |
| Country | 3 |
| Inspection city | Belfast |
| Inspection start date | Nov 26, 2007 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: